Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGPS1 | O95749 | 1/20 | 0.53 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL31207551 | 0.98 | GGPS1 (0.51) | GGPS1PABPC1KMT2AATMGLA | |
| Hydrochloric Acid SCHEMBL31207622 | 0.98 | GGPS1 (0.51) | GGPS1PABPC1KMT2AATMGLA | |
| Bromide SCHEMBL15941512 | 0.98 | GGPS1 (0.51) | GGPS1PABPC1KMT2AATMGLA | |
| Trifluoromethanesulfonic Acid SCHEMBL11889602 | 0.84 | GGPS1 (0.48) | GGPS1PABPC1KMT2AATMGLA | |
| SCHEMBL4235612 | 0.80 | GGPS1 (0.43) | GGPS1PABPC1KMT2AATMGLA | |
| Hydrochloric Acid SCHEMBL1883725 | 0.79 | GGPS1 (0.42) | GGPS1PABPC1KMT2AATMLMNA | |
| Bromide SCHEMBL18838890 | 0.79 | KMT2A (0.45) | GGPS1PABPC1KMT2AATMGLA | |
| SCHEMBL6114658 | 0.78 | PABPC1 (0.50) | GGPS1PABPC1KMT2AATMLMNA | |
| SCHEMBL6114429 | 0.78 | PABPC1 (0.50) | GGPS1PABPC1KMT2AATMLMNA | |
| SCHEMBL18609645 | 0.78 | KDM4E (0.53) | GGPS1GLAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9722281-B2 | Processes for preparing 1-alkyl-3-alkyl-pyridinium bromide and uses thereof as additives in electrochemical cells | BROMINE COMPOUNDS LTD. (IL) | 2017-08-01 | — | — | US | disclosed |
| US-20150372351-A1 | PROCESSES FOR PREPARING L-ALKYL-3-ALKYL-PYRIDINIUM BROMIDE AND USES THEREOF AS ADDITIVES IN ELECTROCHEMICAL CELLS | BROMINE COMPOUNDS LTD. (IL) | 2015-12-24 | — | — | US | disclosed |
| WO-2009040107-A2 | METHOD FOR THE PRODUCTION OF METAL-CONTAINING NANOPARTICLES | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2009-04-02 | — | — | WO | disclosed |
| EP-1442001-B1 | METHOD FOR ELIMINATING POLARIZABLE IMPURITIES FROM HYDROCARBONS AND HYDROCARBON MIXTURES | MERCK PATENT GMBH (DE) | 2008-08-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150372351-A1 | PROCESSES FOR PREPARING L-ALKYL-3-ALKYL-PYRIDINIUM BROMIDE AND USES THEREOF AS ADDITIVES IN ELECTROCHEMICAL CELLS | PLP2, PLPBP, AZI2 | GGPS1 3994/4885PABPC1 1480/4885KMT2A 971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.